Month: November 2024
KEI closing statement at INB 12
KEI closing statement at INB 12 Geneva Friday, 15 November 2024 We welcome the decision to provide daily access to the negotiating texts, but more needs to be done on transparency. The excessive secrecy surrounding the WHO pandemic treaty is… Continue Reading
INB12: KEI statement on Article 11 on the transfer of technology and know-how for the production of pandemic related health products
On Thursday, 14 November 2024, Knowledge Ecology International (KEI) delivered the following statement on Article 11 on the transfer of technology and know-how for the production of pandemic related health products. In several interventions and in talks with negotiators, KEI… Continue Reading
KEI Briefing Note 2024:8. The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
KEI Briefing Note 2024:8, The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
INB12: KEI talking points on Article 11 Transfer of technology and know-how for the production of pandemic-related health products
KEI talking points on Article 11 7 November 2024 The proposed New 1(j) footnote under Article 11 for INB12 is a complex way of saying that countries will make efforts to negotiate voluntary agreements on technology transfer, but if that… Continue Reading
Proposal for Addition Of Risdiplam to WHO Model List Of Essential Medicines, for the treatment of Spinal Muscular Atrophy (SMA).
On November 1, 2024, Knowledge Ecology International (KEI) submitted a proposal for the addition of risdiplam to the World Health Organization’s (WHO) Model List of Essential Medicine (EML). You can access the full proposal here: risdiplam2WHOEML1Nov2024 The EML, updated every… Continue Reading